JP7212678B2 - 診断用デバイスおよびシステム - Google Patents
診断用デバイスおよびシステム Download PDFInfo
- Publication number
- JP7212678B2 JP7212678B2 JP2020515881A JP2020515881A JP7212678B2 JP 7212678 B2 JP7212678 B2 JP 7212678B2 JP 2020515881 A JP2020515881 A JP 2020515881A JP 2020515881 A JP2020515881 A JP 2020515881A JP 7212678 B2 JP7212678 B2 JP 7212678B2
- Authority
- JP
- Japan
- Prior art keywords
- beads
- diagnostic device
- portable diagnostic
- assay
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011324 bead Substances 0.000 claims description 294
- 239000000523 sample Substances 0.000 claims description 181
- 238000003556 assay Methods 0.000 claims description 89
- 210000004369 blood Anatomy 0.000 claims description 65
- 239000008280 blood Substances 0.000 claims description 65
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 50
- 239000012491 analyte Substances 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 29
- 230000009089 cytolysis Effects 0.000 claims description 27
- 239000012528 membrane Substances 0.000 claims description 24
- 230000033001 locomotion Effects 0.000 claims description 23
- 230000002934 lysing effect Effects 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 239000002105 nanoparticle Substances 0.000 claims description 9
- 210000000234 capsid Anatomy 0.000 claims description 8
- 101710163270 Nuclease Proteins 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 210000000170 cell membrane Anatomy 0.000 claims description 5
- 229910000859 α-Fe Inorganic materials 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 230000004700 cellular uptake Effects 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 238000000527 sonication Methods 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 238000005370 electroosmosis Methods 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000003921 oil Substances 0.000 description 39
- 230000004888 barrier function Effects 0.000 description 32
- 239000006166 lysate Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000002245 particle Substances 0.000 description 21
- 229920002477 rna polymer Polymers 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 239000000463 material Substances 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- 230000000295 complement effect Effects 0.000 description 14
- 238000002156 mixing Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 230000007246 mechanism Effects 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 238000000576 coating method Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 238000013459 approach Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000001177 retroviral effect Effects 0.000 description 8
- 238000007789 sealing Methods 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 239000006249 magnetic particle Substances 0.000 description 6
- 230000005499 meniscus Effects 0.000 description 6
- 238000011002 quantification Methods 0.000 description 6
- 238000007306 functionalization reaction Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000012139 lysis buffer Substances 0.000 description 5
- 239000011325 microbead Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000004065 semiconductor Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000011948 assay development Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108700039887 Essential Genes Proteins 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000010936 aqueous wash Methods 0.000 description 3
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 3
- 229910002113 barium titanate Inorganic materials 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 238000011045 prefiltration Methods 0.000 description 3
- 239000012508 resin bead Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 108091006106 transcriptional activators Proteins 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 101000652337 Homo sapiens Transcription factor SOX-21 Proteins 0.000 description 2
- 229910052779 Neodymium Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 102100030247 Transcription factor SOX-21 Human genes 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 108091092259 cell-free RNA Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- -1 eluate Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 208000037408 Device failure Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- 241000396085 Gymnomuraena zebra Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108010071384 Peptide T Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010057517 Strep-avidin conjugated horseradish peroxidase Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000007836 assay cartridge Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 238000009658 destructive testing Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229910001338 liquidmetal Inorganic materials 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001921 nucleic acid quantification Methods 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000005501 phase interface Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/042—Caps; Plugs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
- B01L2300/047—Additional chamber, reservoir
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2547/00—Reactions characterised by the features used to prevent contamination
- C12Q2547/10—Reactions characterised by the features used to prevent contamination the purpose being preventing contamination
- C12Q2547/107—Use of permeable barriers, e.g. waxes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/143—Magnetism, e.g. magnetic label
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/149—Particles, e.g. beads
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Fluid Mechanics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17192153 | 2017-09-20 | ||
| EP17192156.2A EP3460077B1 (en) | 2017-09-20 | 2017-09-20 | Diagnostic device and system |
| EP17192153.9 | 2017-09-20 | ||
| EP17192156.2 | 2017-09-20 | ||
| EP17202859 | 2017-11-21 | ||
| EP17202859.9 | 2017-11-21 | ||
| PCT/EP2018/074058 WO2019057515A1 (en) | 2017-09-20 | 2018-09-06 | DIAGNOSTIC SYSTEM AND DEVICE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020533993A JP2020533993A (ja) | 2020-11-26 |
| JP2020533993A5 JP2020533993A5 (enExample) | 2021-07-26 |
| JP7212678B2 true JP7212678B2 (ja) | 2023-01-25 |
Family
ID=63407236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515881A Active JP7212678B2 (ja) | 2017-09-20 | 2018-09-06 | 診断用デバイスおよびシステム |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US11459601B2 (enExample) |
| EP (2) | EP4219751A1 (enExample) |
| JP (1) | JP7212678B2 (enExample) |
| CN (1) | CN111108216B (enExample) |
| WO (1) | WO2019057515A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3080294B1 (en) | 2013-12-12 | 2018-06-13 | Altratech Limited | A capacitive sensor and method of use |
| WO2015086652A1 (en) | 2013-12-12 | 2015-06-18 | Altra Tech Limited | A sample preparation method and apparatus |
| WO2019057515A1 (en) | 2017-09-20 | 2019-03-28 | Altratech Limited | DIAGNOSTIC SYSTEM AND DEVICE |
| CN120082430A (zh) * | 2020-06-19 | 2025-06-03 | 中国疾病预防控制中心病毒病预防控制所 | 一种样品处理及检测装置 |
| KR102682605B1 (ko) * | 2021-11-03 | 2024-07-09 | 주식회사 위즈바이오솔루션 | 일체형 분자 진단 장치 및 이를 이용한 분자 진단 방법 |
| JP2025504676A (ja) * | 2022-01-28 | 2025-02-14 | アルトラテック・リミテッド | 微生物学的用途のための単一ビーズ静電容量検出器 |
| CN115646562B (zh) * | 2022-09-27 | 2023-08-11 | 郑州大学 | 基于微磁作用的操控芯片、检测组件和检测系统、方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011516034A (ja) | 2008-02-29 | 2011-05-26 | ノースウエスタン ユニバーシティ | 生物反応促進用バリア |
| JP2015084657A (ja) | 2013-10-28 | 2015-05-07 | セイコーエプソン株式会社 | 核酸抽出用デバイス |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0213825A3 (en) | 1985-08-22 | 1989-04-26 | Molecular Devices Corporation | Multiple chemically modulated capacitance |
| US4822566A (en) | 1985-11-19 | 1989-04-18 | The Johns Hopkins University | Optimized capacitive sensor for chemical analysis and measurement |
| WO1988010272A1 (en) | 1987-06-26 | 1988-12-29 | Garth Alexander Nicholson | Method of preserving a body fluid sample, prior to assay for hiv (aids) infection |
| US5139685A (en) | 1991-03-26 | 1992-08-18 | Gds Technology, Inc. | Blood separation filter assembly and method |
| US5413924A (en) | 1992-02-13 | 1995-05-09 | Kosak; Kenneth M. | Preparation of wax beads containing a reagent for release by heating |
| US5378879A (en) | 1993-04-20 | 1995-01-03 | Raychem Corporation | Induction heating of loaded materials |
| US5679519A (en) | 1995-05-09 | 1997-10-21 | Oprandy; John J. | Multi-label complex for enhanced sensitivity in electrochemiluminescence assay |
| US6391265B1 (en) | 1996-08-26 | 2002-05-21 | Biosite Diagnostics, Inc. | Devices incorporating filters for filtering fluid samples |
| SE9703314D0 (sv) | 1997-09-15 | 1997-09-15 | Sangtec Medical Ab | Capacity affinity sensor |
| DE19822123C2 (de) | 1997-11-21 | 2003-02-06 | Meinhard Knoll | Verfahren und Vorrichtung zum Nachweis von Analyten |
| US6022324A (en) | 1998-01-02 | 2000-02-08 | Skinner; Bruce A. J. | Biopsy instrument |
| AU1241000A (en) | 1998-10-27 | 2000-05-15 | Clinical Micro Sensors, Inc. | Detection of target analytes using particles and electrodes |
| WO2000039335A1 (en) | 1998-12-24 | 2000-07-06 | Aclara Biosciences, Inc. | Individually addressable solid surfaces for multiplexed operations |
| EP1212458A4 (en) | 1999-07-30 | 2005-01-05 | Surromed Inc | INSTRUMENTS, METHODS AND REAGENTS FOR PLASMON SURFACE RESONANCE |
| US20060091006A1 (en) | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
| US6962906B2 (en) | 2000-03-14 | 2005-11-08 | Active Motif | Oligonucleotide analogues, methods of synthesis and methods of use |
| US20040005582A1 (en) | 2000-08-10 | 2004-01-08 | Nanobiodynamics, Incorporated | Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators |
| AUPR142500A0 (en) | 2000-11-13 | 2000-12-07 | Human Genetic Signatures Pty Ltd | A peptide nucleic acid-based assay for the detection of specific nucleic acid sequences |
| KR20020063359A (ko) | 2001-01-27 | 2002-08-03 | 일렉트론 바이오 (주) | 핵산 및 올리거뉴클레오티드의 상보적 이중결합의 특정서열에 특이적으로 반응하는 절단기법을 이용한 핵산 혼성분석 방법 및 장치 |
| US6428962B1 (en) | 2001-02-12 | 2002-08-06 | Dna Analysis, Inc. | Nucleic acid collection barrier method and apparatus |
| US20020168663A1 (en) | 2001-02-27 | 2002-11-14 | Phan Brigitte Chau | Methods for DNA conjugation onto solid phase including related optical biodiscs and disc drive systems |
| US20060040286A1 (en) | 2001-03-28 | 2006-02-23 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
| US20040023253A1 (en) | 2001-06-11 | 2004-02-05 | Sandeep Kunwar | Device structure for closely spaced electrodes |
| AU2002329186A1 (en) | 2001-06-21 | 2003-01-08 | Virginia Tech Intellectual Properties, Inc. | Electro-optical detection device |
| US20050101841A9 (en) | 2001-12-04 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Healthcare networks with biosensors |
| US7691326B2 (en) | 2002-01-04 | 2010-04-06 | Sorenson Genomics, L.L.C. | System for non-invasive extraction, secure handling and storage and facile processing and facile processing of a specimen |
| US8154093B2 (en) | 2002-01-16 | 2012-04-10 | Nanomix, Inc. | Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices |
| JP3810713B2 (ja) | 2002-07-25 | 2006-08-16 | 独立行政法人科学技術振興機構 | 抗原抗体反応検出方法及び装置 |
| US7176036B2 (en) | 2002-09-20 | 2007-02-13 | Arrowhead Center, Inc. | Electroactive microspheres and methods |
| FI120863B (fi) | 2002-10-18 | 2010-04-15 | Biocontrol Systems Inc | Magneettinen siirtomenetelmä ja mikropartikkelien siirtolaite |
| EP1603674B1 (en) | 2003-02-05 | 2016-01-06 | Iquum, Inc. | Sample processing |
| DE10319155B4 (de) | 2003-04-29 | 2008-02-14 | Bruker Daltonik Gmbh | Elektrisch auslesbare Bindungen von Analytmolekülen an immobilisierten Sondenmolekülen |
| KR20060052889A (ko) | 2003-07-30 | 2006-05-19 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 생체 활성 분자 사이의 결합을 결정하기 위한 자기 입자의사용 |
| GB0319671D0 (en) | 2003-08-21 | 2003-09-24 | Secr Defence | Apparatus for processing a fluid sample |
| US20050069905A1 (en) | 2003-09-30 | 2005-03-31 | Carl Myerholtz | Detection of molecular binding events |
| US7554134B2 (en) | 2004-04-02 | 2009-06-30 | ChipSensors Limited | Integrated CMOS porous sensor |
| CA2506961C (en) | 2004-05-11 | 2013-05-07 | Inrad, Inc. | Core biopsy device |
| US7785785B2 (en) | 2004-11-12 | 2010-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
| US20060205061A1 (en) | 2004-11-24 | 2006-09-14 | California Institute Of Technology | Biosensors based upon actuated desorption |
| CA2592204C (en) | 2004-12-23 | 2013-03-12 | I-Stat Corporation | Nucleic acid diagnostics system and methods |
| DE102005029809B4 (de) | 2005-06-27 | 2007-04-26 | Siemens Ag | Vorrichtung und Verfahren zur Aufbereitung einer Probe für eine Analyse und Vorrichtung und Verfahren zur Analyse einer Probe |
| ES2301296B1 (es) | 2005-09-16 | 2009-05-29 | Consejo Superior Investig. Cientificas | Manoparticula biosensora, procedimiento de elaboracion y sus aplicaciones. |
| US8841069B2 (en) | 2005-12-29 | 2014-09-23 | Korea Materials & Analysis Corporation | Dendron-mediated DNA virus detection |
| WO2007106580A2 (en) | 2006-03-15 | 2007-09-20 | Micronics, Inc. | Rapid magnetic flow assays |
| AU2007334393A1 (en) | 2006-12-14 | 2008-06-26 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US7993525B2 (en) | 2006-12-29 | 2011-08-09 | Intel Corporation | Device and method for particle complex handling |
| JP2008167722A (ja) | 2007-01-15 | 2008-07-24 | Konica Minolta Medical & Graphic Inc | 磁性支持体上での加熱による核酸単離方法 |
| JP5026873B2 (ja) | 2007-07-04 | 2012-09-19 | 株式会社船井電機新応用技術研究所 | 酵素電極、酵素電極の製造方法及び酵素センサ |
| EP2172564A1 (en) | 2008-10-06 | 2010-04-07 | Sony Corporation | A method of derivatising an analyte for subsequent detection through a nucleic acid based sensor |
| US8106428B2 (en) | 2009-03-03 | 2012-01-31 | Board Of Regents, The University Of Texas System | Nano-scale bridge biosensors |
| EP2233920B1 (en) | 2009-03-27 | 2017-08-16 | ams international AG | A sensor device and a method of manufacturing the same |
| GB2469071A (en) | 2009-03-31 | 2010-10-06 | Diamatrix Ltd | Electrochemical test device |
| US9005987B2 (en) | 2009-04-16 | 2015-04-14 | University Of Southern California | Methods for quantitative target detection and related devices and systems |
| EP2429704A2 (en) | 2009-05-14 | 2012-03-21 | Streck Inc. | Sample processing cassette, system, and method |
| EP2462051A4 (en) | 2009-08-07 | 2013-06-26 | Nanomix Inc | MAGNETIC CARBON NANOTUBES BASED BIO RECOGNITION |
| US8202693B2 (en) | 2009-11-24 | 2012-06-19 | Omega Bio-Tek, Inc. | Method of isolation of nucleic acids |
| US20130045267A1 (en) | 2010-02-05 | 2013-02-21 | University Of Rochester | Methods of using agents that modulate claudin expression |
| US20130240376A1 (en) | 2010-09-02 | 2013-09-19 | Heed Diagnostics Aps | Electrochemical detection of analyte |
| EP2670311A1 (en) | 2011-01-31 | 2013-12-11 | Boston Scientific Scimed, Inc. | Distal tip configurations for biopsy with eus fna |
| CN103299179A (zh) | 2011-06-06 | 2013-09-11 | 松下电器产业株式会社 | 焦磷酸的测定方法以及snp分型方法 |
| KR101542549B1 (ko) | 2011-09-02 | 2015-08-06 | 산디아 코포레이션 | 바이오센싱 및 약물 전달을 위한 마이크로니들 어레이 |
| WO2015086652A1 (en) * | 2013-12-12 | 2015-06-18 | Altra Tech Limited | A sample preparation method and apparatus |
| EP2883961B8 (en) | 2013-12-12 | 2017-09-27 | Altratech Limited | A nucleic acid analysis method and apparatus |
| EP3080294B1 (en) | 2013-12-12 | 2018-06-13 | Altratech Limited | A capacitive sensor and method of use |
| EP3230710B1 (en) | 2014-12-10 | 2023-06-07 | Altratech Limited | A sampling apparatus |
| CN108463719B (zh) | 2015-12-28 | 2021-12-21 | 生命扫描苏格兰有限公司 | 具有电极电压感测连接件的基于电化学的分析测试条以及与其一起使用的手持式测试仪 |
| WO2019057513A1 (en) | 2017-09-20 | 2019-03-28 | University College Cork - National University Of Ireland, Cork | DIAGNOSTIC SENSOR |
| WO2019057515A1 (en) | 2017-09-20 | 2019-03-28 | Altratech Limited | DIAGNOSTIC SYSTEM AND DEVICE |
-
2018
- 2018-09-06 WO PCT/EP2018/074058 patent/WO2019057515A1/en not_active Ceased
- 2018-09-06 JP JP2020515881A patent/JP7212678B2/ja active Active
- 2018-09-06 US US16/647,795 patent/US11459601B2/en active Active
- 2018-09-06 CN CN201880061420.7A patent/CN111108216B/zh active Active
- 2018-09-06 EP EP23162199.6A patent/EP4219751A1/en not_active Withdrawn
- 2018-09-06 EP EP18762114.9A patent/EP3684950B1/en active Active
-
2022
- 2022-10-03 US US17/958,819 patent/US20230094539A1/en not_active Abandoned
-
2024
- 2024-03-11 US US18/601,452 patent/US20240218429A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011516034A (ja) | 2008-02-29 | 2011-05-26 | ノースウエスタン ユニバーシティ | 生物反応促進用バリア |
| JP2015084657A (ja) | 2013-10-28 | 2015-05-07 | セイコーエプソン株式会社 | 核酸抽出用デバイス |
Also Published As
| Publication number | Publication date |
|---|---|
| US20200216884A1 (en) | 2020-07-09 |
| US20240218429A1 (en) | 2024-07-04 |
| CN111108216A (zh) | 2020-05-05 |
| EP4219751A1 (en) | 2023-08-02 |
| EP3684950B1 (en) | 2023-04-26 |
| US20230094539A1 (en) | 2023-03-30 |
| JP2020533993A (ja) | 2020-11-26 |
| US11459601B2 (en) | 2022-10-04 |
| WO2019057515A1 (en) | 2019-03-28 |
| EP3684950A1 (en) | 2020-07-29 |
| CN111108216B (zh) | 2024-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7212678B2 (ja) | 診断用デバイスおよびシステム | |
| CN106660058B (zh) | 用于执行自动化离心分离的设备、系统和方法 | |
| US6664104B2 (en) | Device incorporating a microfluidic chip for separating analyte from a sample | |
| US6893879B2 (en) | Method for separating analyte from a sample | |
| US7914994B2 (en) | Method for separating an analyte from a sample | |
| US20180266951A1 (en) | Flow cells utilizing surface-attached structures, and related systems and methods | |
| TW200406487A (en) | Microfluidic system for analyzing nucleic acids | |
| JP2006520190A (ja) | 流体の微小流体的な操作、増幅、および分析(例えば、細菌アッセイおよびアンチグロブリン試験)のための方法およびシステム | |
| JP2008076396A (ja) | 診断テストシステム | |
| WO2005059929A2 (en) | Magnetic rod apparatus and method for manipulating magnetic particles for detecting analytes | |
| EP3460077B1 (en) | Diagnostic device and system | |
| US20240376524A1 (en) | Integrated nucleic acid analysis system and method for measuring target nucleic acid in sample | |
| G. Mauk et al. | Translating nucleic acid amplification assays to the microscale: lab on a chip for point-of-care molecular diagnostics | |
| CN117282475A (zh) | 从数字微流控芯片中取出液滴的方法 | |
| CN121160436A (en) | Digital micro-fluidic chip, integrated sequencing system and method | |
| WO2011156687A1 (en) | Apparatus for fluidic sample processing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210609 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210609 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220712 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220831 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221227 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230113 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7212678 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |